A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...

Drug companies in the U.S. face few restraints on what to charge for their products. A bipartisan bill would penalize those ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Given the complexity of controlled substance regulations, organizations must take a proactive approach to compliance and ...

As sure as the sun rises, prescription medicine use and total drug spending continue to increase in the U.S. | Last year's ...

Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

The U.S. Food and Drug Administration is warning Americans about the ever-increasing and potentially deadly recreational use ...

A “tidal wave” of a recently criminalised substance used to drug and sexually assault unsuspecting victims has reached ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Opposing interests in the health care world are escalating their fight over an Illinois bill targeting the 340B drug discount ...

Swiss-headquartered Sandoz, which spun off from Novartis in 2023, is one of the world's largest makers of generic and ...